Bactiguard Holding AB’s Annual and Sustainability Report 2023
The Annual and Sustainably Report 2023 for Bactiguard Holding AB (publ) is now available at www.bactiguard.com
Bactiguard underwent a major transformation in 2023. The company sharpened its strategy and is now focused on licensing the infection preventing coating technology to leading global MedTech companies. The license partnerships give Bactiguard global reach and the ability to scale the business in a cost-effective way while at the same time contribute to a healthier world by preventing infections.
“Our strategy is to support leading global MedTech companies in launching medical devices with our unique infection prevention coating technology - their products become premium and enables them to outperform competitors. We also create opportunities for the license partner to increase their market shares”, Thomas von Koch comments in his CEO statement.
Read more in Bactiguard Holding AB’s Annual and Sustainability Report 2023 here
Bactiguard Holding AB (publ) is obliged to make this information public under the Securities Markets Act. The information was submitted for publication at 08.00 CET on 11 April 2024.
For more information, please contact:
Patrick Bach, CFO +46 761 295 911
Nina Nornholm, Head of Communication & Investor Relations +46 708 550 356
About Bactiguard
Bactiguard is a global MedTech company developing safe and biocompatible technology to prevent medical device related infections. The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine. Bactiguard operates through license partnerships with leading global MedTech companies that apply the technology to their medical devices and sell them under their own brand or co-branded with Bactiguard. The company also has a portfolio of wound management products.
Bactiguard is headquartered in Stockholm and listed on Nasdaq Stockholm.
Read more about Bactiguard: www.bactiguard.com
Follow Bactiguard on LinkedIn
